Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,225.20Prev. Close
1,218.80Volume
9,194Total traded value
1.12 CrUpper Circuit
1,462.50Lower Circuit
975.10Fundamentals
| Market Cap | ₹6,456Cr |
| ROE | 16.74% |
| P/E Ratio(TTM) | 60.67 |
| EPS(TTM) | 20.08 |
| P/B Ratio | 13.13 |
| Dividend Yield | 1.72% |
| Industry P/E | 67.94 |
| Book Value | 92.81 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Thyrocare Technologies
Since its establishment in 1996, Thyrocare has grown into one of the country's largest fully automated diagnostic laboratory chains, headquartered in Navi Mumbai. The company's core mission is to ensure that everyone has access to good quality and affordable diagnostic services for their health needs. Its services are accessible across more than 4,600 pin codes in India, supported by a network of 29 NABL-certified labs.;
| Parent Organisation | Thyrocare Technologies |
| Managing Director | Mr. Rahul Guha |
| NSE Symbol | THYROCARE |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 55.39 | ||
| Metropolis Healthcare | NA (0.00%) | 70.91 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 71.82 | ||
| Krsnaa Diagnostics | NA (0.00%) | 34.66 |